Purifloh Limited (AU:PO3) has released an update.
PuriflOH Limited is making strides towards commercializing its innovative technology for PFAS contamination treatment. The company is engaging in pilot trials and strategic partnerships, including a collaboration with the Department of Defence, to optimize and expand the application of their technology. Despite financial constraints, PuriflOH has effectively managed its resources to advance its R&D efforts, focusing on long-term commercial success.
For further insights into AU:PO3 stock, check out TipRanks’ Stock Analysis page.
